DUBLIN–(BUSINESS WIRE)–The “The Global Nanobubbles Market 2026-2036” report has been added to ResearchAndMarkets.com’s offering. The Global Nanobubbles Market Report 2026-2036 provides detailed analysis, revenue forecasts, and strategic insights into the rapidly evolving nanobubble industry from 2026 through 2036. This report delivers actionable intelligence for investors, manufacturers, end users, and stakeholders seeking to understand market dynamics, … [Read more…]

SEATTLE–(BUSINESS WIRE)–Molina Healthcare of Washington (“Molina”), in collaboration with The MolinaCares Accord (“MolinaCares”), presented a $75,000 grant to the Seattle Indian Health Board (“SIHB”) to support the launch of the Thunderbird Treatment Center—a 92-bed residential treatment facility opening on Vashon Island. The funding will benefit the completion of the center’s new location. Substance use disorder … [Read more…]

– Veligrotug BLA accepted for thyroid eye disease (TED) with PDUFA target action date of June 30, 2026 under Priority Review; commercial preparations on track – – Topline phase 3 results for subcutaneous elegrobart (VRDN-003) on track for Q1 2026 for REVEAL-1 and Q2 2026 for REVEAL-2 for active and chronic TED, respectively – – … [Read more…]

Novel capsid technology to enable convenient delivery in the doctor’s office of IKAR-003 for intermediate AMD, designed to prevent progression to sight-threatening disease NORWICH, England & CHICAGO–(BUSINESS WIRE)–#BioTechNews–Ikarovec Ltd, which is developing dual-pathway gene therapies for vision-threatening retinal diseases, and VectorBuilder, a global leader in gene delivery technologies, have entered into an exclusive worldwide option … [Read more…]

Study showed a statistically significant disease-free survival (DFS) benefit in all SignateraTM-positive patients following blinded central review AUSTIN, Texas–(BUSINESS WIRE)–Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that new data from the ALTAIR trial will be presented at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium … [Read more…]

LONG BEACH, Calif.–(BUSINESS WIRE)–Reproductive Partners Medical Group (RPMG), a nationally respected leader in fertility care and family building, announced the relocation of its Westminster fertility clinic to a newly designed, patient-focused facility complete with lab and surgery center in Long Beach, California. The move is designed to better serve patients across greater Los Angeles and … [Read more…]

PLC partners with a modern, data-driven clinical platform to enhance resident care, streamline staff workflows, and support scalable growth MILWAUKEE–(BUSINESS WIRE)–#assistedliving—Priority Life Care (PLC), a senior living provider serving more than 4,000 residents across 60+ communities, today announced a major investment in its technology infrastructure through a new enterprise partnership with ECP. ECP is the … [Read more…]

Priority Health becomes four-state health plan GRAND RAPIDS, Mich.–(BUSINESS WIRE)–Priority Health, a Michigan-based health plan serving more than 1.3 million members, has completed a transaction with Group Health Cooperative of Eau Claire (the Cooperative), a community-based health plan in Wisconsin serving more than 61,000 members, that establishes Priority Health as the sole governing member of … [Read more…]

BOSTON–(BUSINESS WIRE)–Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage therapeutics company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that Daphne Zohar, Co-Founder and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 9:30 a.m. PST. Ms. Zohar will … [Read more…]

BOSTON & DAEJEON, South Korea–(BUSINESS WIRE)–#ADC—Orum Therapeutics (Orum or the Company) (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the appointment of Chad May, Ph.D., as Chief Scientific Officer (CSO). Dr. May brings more than 20 years of oncology and immunology research experience with a track record of advancing … [Read more…]